Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genus plc ( (GB:GNS) ) has provided an announcement.
Genus reported a stronger-than-expected performance for the first half of its 2026 financial year, with adjusted profit before tax (excluding a milestone payment) anticipated at about £50m, ahead of internal expectations, and around £55.6m including the milestone. Driven by robust trading at its PIC pork genetics unit and in-line performance at ABS, the board now forecasts full-year adjusted profit before tax (excluding the milestone) to come in moderately above the top end of current market expectations, signalling positive momentum in core operations. The group also confirmed that China’s SASAC has approved the formation of its porcine joint venture in China, triggering a final $7.5m milestone payment from partner BCA, with completion and cash receipt expected in the fiscal third quarter, underscoring Genus’s strategic push into the Chinese pork market and reinforcing its growth prospects in a key global protein sector.
The most recent analyst rating on (GB:GNS) stock is a Hold with a £2836.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.
Spark’s Take on GB:GNS Stock
According to Spark, TipRanks’ AI Analyst, GB:GNS is a Neutral.
Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.
To see Spark’s full report on GB:GNS stock, click here.
More about Genus plc
Genus plc is a world-leading animal genetics company that applies biotechnology to improve livestock breeding, supplying added-value genetic products to dairy, beef and pork producers in more than 75 countries under its ABS (cattle) and PIC (pigs) brands. Its portfolio includes semen, embryos and breeding animals designed to enhance production efficiency and quality across global dairy and meat supply chains, underpinned by proprietary breeding lines, a global distribution network and innovations such as its PRRS-resistant pig, which is awaiting further regulatory approvals for wider commercialisation.
Average Trading Volume: 152,025
Technical Sentiment Signal: Buy
Current Market Cap: £1.72B
Find detailed analytics on GNS stock on TipRanks’ Stock Analysis page.